These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 7974204)

  • 1. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux.
    Stephans SE; Yamamoto BK
    Synapse; 1994 Jul; 17(3):203-9. PubMed ID: 7974204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
    Bowyer JF; Davies DL; Schmued L; Broening HW; Newport GD; Slikker W; Holson RR
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1571-80. PubMed ID: 8138969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
    Abekawa T
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow.
    Weihmuller FB; O'Dell SJ; Marshall JF
    Synapse; 1992 Jun; 11(2):155-63. PubMed ID: 1626313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
    Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
    Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lubeluzole on the methamphetamine-induced increase in extracellular glutamate and the long-term depletion of striatal dopamine.
    Wallace TL; Vorhees CV; Gudelsky GA
    Synapse; 2001 May; 40(2):95-101. PubMed ID: 11252020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitotoxic striatal lesions protect against subsequent methamphetamine-induced dopamine depletions.
    O'Dell SJ; Weihmuller FB; McPherson RJ; Marshall JF
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1319-25. PubMed ID: 7912281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of MK-801 with glutamate-, glutamine- and methamphetamine-evoked release of [3H]dopamine from striatal slices.
    Bowyer JF; Scallet AC; Holson RR; Lipe GW; Slikker W; Ali SF
    J Pharmacol Exp Ther; 1991 Apr; 257(1):262-70. PubMed ID: 1673475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
    Nash JF; Brodkin J
    J Pharmacol Exp Ther; 1991 Nov; 259(2):820-5. PubMed ID: 1682486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methamphetamine, morphine, and their combination: acute changes in striatal dopaminergic transmission evaluated by microdialysis in awake rats.
    Pereira FC; Lourenço E; Milhazes N; Morgadinho T; Ribeiro CF; Ali SF; Macedo TR
    Ann N Y Acad Sci; 2006 Aug; 1074():160-73. PubMed ID: 17105914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
    Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR
    Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
    Wagstaff JD; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of methamphetamine on the production of free radicals and oxidative stress.
    Yamamoto BK; Zhu W
    J Pharmacol Exp Ther; 1998 Oct; 287(1):107-14. PubMed ID: 9765328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
    Chapman DE; Hanson GR; Kesner RP; Keefe KA
    J Pharmacol Exp Ther; 2001 Feb; 296(2):520-7. PubMed ID: 11160639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular glutamate levels increase with age in the lateral striatum: potential involvement of presynaptic D-2 receptors.
    Donzanti BA; Hite JF; Yamamoto BK
    Synapse; 1993 Apr; 13(4):376-82. PubMed ID: 8097598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine.
    Cass WA
    J Pharmacol Exp Ther; 1997 Jan; 280(1):105-13. PubMed ID: 8996187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.
    Metzger RR; Haughey HM; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1077-85. PubMed ID: 11082443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
    Crawford CA; Williams MT; Newman ER; McDougall SA; Vorhees CV
    Synapse; 2003 Jun; 48(3):131-7. PubMed ID: 12645038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine.
    Cass WA; Smith MP; Peters LE
    Ann N Y Acad Sci; 2006 Aug; 1074():261-71. PubMed ID: 17105922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.
    Zhang L; Kitaichi K; Fujimoto Y; Nakayama H; Shimizu E; Iyo M; Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1381-93. PubMed ID: 16839653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.